Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Gan & Lee Pharmaceuticals
Gan & Lee Pharmaceuticals
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Gan & Lee Pharmaceuticals
Total Funding
$46.4 M
Gan & Lee Pharmaceuticals Summary
Company Summary
Overview
Gan & Lee Pharmaceuticals (甘李药业) is a high-tech biopharmaceutical company engaged in the R&D, production, and marketing of insulin glargine and insulin lispro. The Сompany has a complete product line for a variety of biosynthetic human insulins.
Type
Private
Status
Active
Founded
1998
HQ
Beijing, CN
|
view all locations
Website
http://ganlee.com/
Cybersecurity rating
ESG rating
40-49 out of 100
|
View all ESG data
Sectors
Healthcare
biotech
diabetes
medical devices
pharma
Homepage
Linkedin
facebook
Table of Contents
Locations
Competitors
Locations
View all
1 location detected
Beijing, Beijing
HQ
China
No.8 Nanfeng West 1st Street
Competitors and Similar Companies
GlucoMetrix
Healthcare - Private
Oramed Pharmaceuticals
Healthcare - Public
Kowa Pharmaceuticals America
Healthcare - Subsidiary
Innoture
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top